Kirill V. Odarenko, Aleksandra V. Sen'kova, Oksana V. Salomatina, Oksana V. Salomatina, Oleg V. Markov, Nariman F. Salakhutdinov, . . . Andrey V. Markov. (2024). Soloxolone para-methylanilide effectively suppresses aggressive phenotype of glioblastoma cells including TGF-β1-induced glial-mesenchymal transition in vitro and inhibits growth of U87 glioblastoma xenografts in mice. Frontiers Media S.A..
Chicago Style (17th ed.) CitationKirill V. Odarenko, Aleksandra V. Sen'kova, Oksana V. Salomatina, Oksana V. Salomatina, Oleg V. Markov, Nariman F. Salakhutdinov, Marina A. Zenkova, and Andrey V. Markov. Soloxolone Para-methylanilide Effectively Suppresses Aggressive Phenotype of Glioblastoma Cells Including TGF-β1-induced Glial-mesenchymal Transition in Vitro and Inhibits Growth of U87 Glioblastoma Xenografts in Mice. Frontiers Media S.A., 2024.
MLA (9th ed.) CitationKirill V. Odarenko, et al. Soloxolone Para-methylanilide Effectively Suppresses Aggressive Phenotype of Glioblastoma Cells Including TGF-β1-induced Glial-mesenchymal Transition in Vitro and Inhibits Growth of U87 Glioblastoma Xenografts in Mice. Frontiers Media S.A., 2024.